Company mentioned on podcasts
Zola Therapeutics
Mentioned on 1 episode by 1 guest across our covered podcasts.
SignalCast may earn commission on purchases via these links. As an Amazon Associate, SignalCast earns from qualifying purchases.
Who mentioned it
- Art KriegAuthor
“Art Krieg, founder of Zola Therapeutics and pioneer of CpG DNA immunotherapy, explains how his new oligonucleotide drug candidate simultaneously activates TLR7, TLR8, and TLR9 receptors”
Mentioned on: The Long Run with Luke Timmerman